Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293034509> ?p ?o ?g. }
- W4293034509 abstract "Cytokine-induced killer cells (CIK) in combination with dendritic cells (DCs) have shown favorable outcomes in renal cell carcinoma (RCC), yet some patients exhibit recurrence or no response to this therapy. In a broader perspective, enhancing the antitumor response of DC-CIK cells may help to address this issue. Considering this, herein, we investigated the effect of anti-CD40 and anti-CTLA-4 antibodies on the antitumor response of DC-CIK cells against RCC cell lines. Our analysis showed that, a) anti-CD40 antibody (G28.5) increased the CD3+CD56+ effector cells of CIK cells by promoting the maturation and activation of DCs, b) G28.5 also increased CTLA-4 expression in CIK cells via DCs, but the increase could be hindered by the CTLA-4 inhibitor (ipilimumab), c) adding ipilimumab was also able to significantly increase the proportion of CD3+CD56+ cells in DC-CIK cells, d) anti-CD40 antibodies predominated over anti-CTLA-4 antibodies for cytotoxicity, apoptotic effect and IFN-γ secretion of DC-CIK cells against RCC cells, e) after ipilimumab treatment, the population of Tregs in CIK cells remained unaffected, but ipilimumab combined with G28.5 significantly reduced the expression of CD28 in CIK cells. Taken together, we suggest that the agonistic anti-CD40 antibody rather than CTLA-4 inhibitor may improve the antitumor response of DC-CIK cells, particularly in RCC. In addition, we pointed towards the yet to be known contribution of CD28 in the crosstalk between anti-CTLA-4 and CIK cells." @default.
- W4293034509 created "2022-08-25" @default.
- W4293034509 creator A5017462100 @default.
- W4293034509 creator A5042086196 @default.
- W4293034509 creator A5042973046 @default.
- W4293034509 creator A5050233418 @default.
- W4293034509 creator A5052553879 @default.
- W4293034509 creator A5074477435 @default.
- W4293034509 creator A5091485777 @default.
- W4293034509 date "2022-08-25" @default.
- W4293034509 modified "2023-10-17" @default.
- W4293034509 title "Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma" @default.
- W4293034509 cites W145180768 @default.
- W4293034509 cites W1567958712 @default.
- W4293034509 cites W163992869 @default.
- W4293034509 cites W1672727064 @default.
- W4293034509 cites W190170602 @default.
- W4293034509 cites W2004630197 @default.
- W4293034509 cites W2013043293 @default.
- W4293034509 cites W2018987206 @default.
- W4293034509 cites W2029208213 @default.
- W4293034509 cites W2032336088 @default.
- W4293034509 cites W2043232367 @default.
- W4293034509 cites W2053248202 @default.
- W4293034509 cites W2060382742 @default.
- W4293034509 cites W2101581360 @default.
- W4293034509 cites W2113618705 @default.
- W4293034509 cites W2133114658 @default.
- W4293034509 cites W2152040036 @default.
- W4293034509 cites W2152899663 @default.
- W4293034509 cites W2172658766 @default.
- W4293034509 cites W2183612735 @default.
- W4293034509 cites W2726542547 @default.
- W4293034509 cites W2730062213 @default.
- W4293034509 cites W2778533252 @default.
- W4293034509 cites W2790795290 @default.
- W4293034509 cites W2809064179 @default.
- W4293034509 cites W2888050979 @default.
- W4293034509 cites W2900061537 @default.
- W4293034509 cites W2997939359 @default.
- W4293034509 cites W3028618058 @default.
- W4293034509 cites W3040490127 @default.
- W4293034509 cites W3082515070 @default.
- W4293034509 cites W3202422882 @default.
- W4293034509 cites W4200516862 @default.
- W4293034509 doi "https://doi.org/10.3389/fimmu.2022.925633" @default.
- W4293034509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36091050" @default.
- W4293034509 hasPublicationYear "2022" @default.
- W4293034509 type Work @default.
- W4293034509 citedByCount "1" @default.
- W4293034509 countsByYear W42930345092023 @default.
- W4293034509 crossrefType "journal-article" @default.
- W4293034509 hasAuthorship W4293034509A5017462100 @default.
- W4293034509 hasAuthorship W4293034509A5042086196 @default.
- W4293034509 hasAuthorship W4293034509A5042973046 @default.
- W4293034509 hasAuthorship W4293034509A5050233418 @default.
- W4293034509 hasAuthorship W4293034509A5052553879 @default.
- W4293034509 hasAuthorship W4293034509A5074477435 @default.
- W4293034509 hasAuthorship W4293034509A5091485777 @default.
- W4293034509 hasBestOaLocation W42930345091 @default.
- W4293034509 hasConcept C148125776 @default.
- W4293034509 hasConcept C154317977 @default.
- W4293034509 hasConcept C159654299 @default.
- W4293034509 hasConcept C202751555 @default.
- W4293034509 hasConcept C203014093 @default.
- W4293034509 hasConcept C21705690 @default.
- W4293034509 hasConcept C2776090121 @default.
- W4293034509 hasConcept C2777701055 @default.
- W4293034509 hasConcept C2781433595 @default.
- W4293034509 hasConcept C39347974 @default.
- W4293034509 hasConcept C40677261 @default.
- W4293034509 hasConcept C502942594 @default.
- W4293034509 hasConcept C542903549 @default.
- W4293034509 hasConcept C55493867 @default.
- W4293034509 hasConcept C71924100 @default.
- W4293034509 hasConcept C86803240 @default.
- W4293034509 hasConcept C8891405 @default.
- W4293034509 hasConceptScore W4293034509C148125776 @default.
- W4293034509 hasConceptScore W4293034509C154317977 @default.
- W4293034509 hasConceptScore W4293034509C159654299 @default.
- W4293034509 hasConceptScore W4293034509C202751555 @default.
- W4293034509 hasConceptScore W4293034509C203014093 @default.
- W4293034509 hasConceptScore W4293034509C21705690 @default.
- W4293034509 hasConceptScore W4293034509C2776090121 @default.
- W4293034509 hasConceptScore W4293034509C2777701055 @default.
- W4293034509 hasConceptScore W4293034509C2781433595 @default.
- W4293034509 hasConceptScore W4293034509C39347974 @default.
- W4293034509 hasConceptScore W4293034509C40677261 @default.
- W4293034509 hasConceptScore W4293034509C502942594 @default.
- W4293034509 hasConceptScore W4293034509C542903549 @default.
- W4293034509 hasConceptScore W4293034509C55493867 @default.
- W4293034509 hasConceptScore W4293034509C71924100 @default.
- W4293034509 hasConceptScore W4293034509C86803240 @default.
- W4293034509 hasConceptScore W4293034509C8891405 @default.
- W4293034509 hasLocation W42930345091 @default.
- W4293034509 hasLocation W42930345092 @default.
- W4293034509 hasLocation W42930345093 @default.
- W4293034509 hasLocation W42930345094 @default.
- W4293034509 hasOpenAccess W4293034509 @default.
- W4293034509 hasPrimaryLocation W42930345091 @default.